<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Salofalk</title><link>http://www.unboundmedicine.com/medline/ebm/research/Salofalk</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Optimizing conventional therapy for inflammatory bowel disease.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19006615/full_citation/Optimizing_conventional_therapy_for_inflammatory_bowel_disease_</link><description>Schwartz M, Cohen R <br/><span class="title">Optimizing conventional therapy for inflammatory bowel disease. [Journal Article]</span><br/><span class="source" title="Current gastroenterology reports">Curr Gastroenterol Rep 2008 Dec; 10(6):585-90.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19006615/abstract/Optimizing_conventional_therapy_for_inflammatory_bowel_disease_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19006615/full_citation/Optimizing_conventional_therapy_for_inflammatory_bowel_disease_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/19006615/Optimizing_conventional_therapy_for_inflammatory_bowel_disease_">Find Related Articles</a> </description></item><item><title>Therapeutic strategies for the management of ulcerative colitis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18985710/full_citation/Therapeutic_strategies_for_the_management_of_ulcerative_colitis_</link><description>Ng SC, Kamm MA <br/><span class="title">Therapeutic strategies for the management of ulcerative colitis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Inflammatory bowel diseases">Inflamm Bowel Dis 2008 Nov 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18985710/abstract/Therapeutic_strategies_for_the_management_of_ulcerative_colitis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18985710/full_citation/Therapeutic_strategies_for_the_management_of_ulcerative_colitis_">Full Citation</a></description></item><item><title>Controversies in Ulcerative Colitis: A Survey Comparing Decision Making of Experts Versus Community Gastroenterologists.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18952199/full_citation/Controversies_in_Ulcerative_Colitis:_A_Survey_Comparing_Decision_Making_of_Experts_Versus_Community_Gastroenterologists_</link><description>Spiegel BM, Ho W, Esrailian E, et al. <br/><span class="title">Controversies in Ulcerative Colitis: A Survey Comparing Decision Making of Experts Versus Community Gastroenterologists. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association">Clin Gastroenterol Hepatol 2008 Sep 4.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18952199/abstract/Controversies_in_Ulcerative_Colitis:_A_Survey_Comparing_Decision_Making_of_Experts_Versus_Community_Gastroenterologists_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18952199/full_citation/Controversies_in_Ulcerative_Colitis:_A_Survey_Comparing_Decision_Making_of_Experts_Versus_Community_Gastroenterologists_">Full Citation</a></description></item><item><title>Progression to Colorectal Neoplasia in Ulcerative Colitis: Effect of Mesalamine.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18848502/full_citation/Progression_to_Colorectal_Neoplasia_in_Ulcerative_Colitis:_Effect_of_Mesalamine_</link><description>Ullman T, Croog V, Harpaz N, et al. <br/><span class="title">Progression to Colorectal Neoplasia in Ulcerative Colitis: Effect of Mesalamine. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association">Clin Gastroenterol Hepatol 2008 Oct 8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18848502/abstract/Progression_to_Colorectal_Neoplasia_in_Ulcerative_Colitis:_Effect_of_Mesalamine_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18848502/full_citation/Progression_to_Colorectal_Neoplasia_in_Ulcerative_Colitis:_Effect_of_Mesalamine_">Full Citation</a></description></item><item><title>Insights into inflammation and influenza.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18843127/full_citation/Insights_into_inflammation_and_influenza_</link><description>Simmons C, Farrar J <br/><span class="title">Insights into inflammation and influenza. [Journal Article]</span><br/><span class="source" title="The New England journal of medicine">N Engl J Med 2008 Oct 9; 359(15):1621-3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18843127/full_citation/Insights_into_inflammation_and_influenza_">Full Citation</a> | <a href="http://content.nejm.org/cgi/pmidlookup%3fview=short%26amp;pmid=18843127%26amp;promo=ONFLNS19">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18843127/Insights_into_inflammation_and_influenza_">Find Related Articles</a> </description></item><item><title>Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18834420/full_citation/Duration_of_remission_and_long_term_prognosis_according_to_the_extent_of_disease_in_patients_with_ulcerative_colitis_on_continuous_mesalamine_treatment_</link><description>Bresci G, Parisi G, Capria A <br/><span class="title">Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment. [Journal Article]</span><br/><span class="source" title="Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland">Colorectal Dis 2008 Oct; 10(8):814-7.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18834420/abstract/Duration_of_remission_and_long_term_prognosis_according_to_the_extent_of_disease_in_patients_with_ulcerative_colitis_on_continuous_mesalamine_treatment_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18834420/full_citation/Duration_of_remission_and_long_term_prognosis_according_to_the_extent_of_disease_in_patients_with_ulcerative_colitis_on_continuous_mesalamine_treatment_">Full Citation</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18834420/Duration_of_remission_and_long_term_prognosis_according_to_the_extent_of_disease_in_patients_with_ulcerative_colitis_on_continuous_mesalamine_treatment_">Find Related Articles</a> </description></item><item><title>Once-daily versus three-times-daily mesalazine granules in active ulcerative colitis: A double-blind, double-dummy, randomised non-inferiority trial.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18832520/full_citation/Once_daily_versus_three_times_daily_mesalazine_granules_in_active_ulcerative_colitis:_A_double_blind_double_dummy_randomised_non_inferiority_trial_</link><description>Kruis W, Kiudelis G, Racz I, et al. <br/><span class="title">Once-daily versus three-times-daily mesalazine granules in active ulcerative colitis: A double-blind, double-dummy, randomised non-inferiority trial. [JOURNAL ARTICLE]</span><br/><span class="source" title="Gut">Gut 2008 Oct 2.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18832520/abstract/Once_daily_versus_three_times_daily_mesalazine_granules_in_active_ulcerative_colitis:_A_double_blind_double_dummy_randomised_non_inferiority_trial_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18832520/full_citation/Once_daily_versus_three_times_daily_mesalazine_granules_in_active_ulcerative_colitis:_A_double_blind_double_dummy_randomised_non_inferiority_trial_">Full Citation</a> | <a href="http://gut.bmj.com/cgi/pmidlookup%3fview=long%26amp;pmid=18832520">Publisher Full Text</a> | <a href="http://www.unboundmedicine.com/medline/ebm/related/18832520/Once_daily_versus_three_times_daily_mesalazine_granules_in_active_ulcerative_colitis:_A_double_blind_double_dummy_randomised_non_inferiority_trial_">Find Related Articles</a> </description></item><item><title>Sustained Delivery of Intact Drug to the Colon: Mesalamine Formulation and Temporal Gastrointestinal Transit Analysis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18821272/full_citation/Sustained_Delivery_of_Intact_Drug_to_the_Colon:_Mesalamine_Formulation_and_Temporal_Gastrointestinal_Transit_Analysis_</link><description>Chuong MC, Christensen JM, Ayres JW <br/><span class="title">Sustained Delivery of Intact Drug to the Colon: Mesalamine Formulation and Temporal Gastrointestinal Transit Analysis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Pharmaceutical development and technology">Pharm Dev Technol 2008 Sep 27.:1-10.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18821272/abstract/Sustained_Delivery_of_Intact_Drug_to_the_Colon:_Mesalamine_Formulation_and_Temporal_Gastrointestinal_Transit_Analysis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18821272/full_citation/Sustained_Delivery_of_Intact_Drug_to_the_Colon:_Mesalamine_Formulation_and_Temporal_Gastrointestinal_Transit_Analysis_">Full Citation</a></description></item><item><title>The effect of mesalamine therapy on quality of life in patients with mildly to moderately active ulcerative colitis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18808446/full_citation/The_effect_of_mesalamine_therapy_on_quality_of_life_in_patients_with_mildly_to_moderately_active_ulcerative_colitis_</link><description>Irvine EJ, Yeh CH, Ramsey D, et al. <br/><span class="title">The effect of mesalamine therapy on quality of life in patients with mildly to moderately active ulcerative colitis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Alimentary pharmacology &amp; therapeutics">Aliment Pharmacol Ther 2008 Sep 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18808446/abstract/The_effect_of_mesalamine_therapy_on_quality_of_life_in_patients_with_mildly_to_moderately_active_ulcerative_colitis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18808446/full_citation/The_effect_of_mesalamine_therapy_on_quality_of_life_in_patients_with_mildly_to_moderately_active_ulcerative_colitis_">Full Citation</a></description></item><item><title>The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18808444/full_citation/The_cost_utility_of_high_dose_oral_mesalazine_for_moderately_active_ulcerative_colitis_</link><description>Buckland A, Bodger K <br/><span class="title">The cost-utility of high dose oral mesalazine for moderately active ulcerative colitis. [JOURNAL ARTICLE]</span><br/><span class="source" title="Alimentary pharmacology &amp; therapeutics">Aliment Pharmacol Ther 2008 Sep 20.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18808444/abstract/The_cost_utility_of_high_dose_oral_mesalazine_for_moderately_active_ulcerative_colitis_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18808444/full_citation/The_cost_utility_of_high_dose_oral_mesalazine_for_moderately_active_ulcerative_colitis_">Full Citation</a></description></item></channel></rss>